Vaccitech | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Conferences Trial results

21 October 2023

ESMO 2023 – Amgen’s Steap1 project spurs cautious optimism

But toxicity will be closely watched in future trials.

Subscribe to Vaccitech